Articles published by LGM Pharma

LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites

Today 7:30 EDT

From LGM Pharma

Via Business Wire

LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories

March 12, 2025

From LGM Pharma

Via Business Wire

LGM Pharma Expands Analytical Testing Services with New Endotoxin and Rapid Sterility Testing Capabilities

October 15, 2024

From LGM Pharma

Via Business Wire

LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional Suppository Manufacturing Capabilities

March 13, 2024

From LGM Pharma

Via Business Wire

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

March 15, 2023

From LGM Pharma

Via Business Wire

LGM Pharma’s Unique Mix of API Sourcing and CDMO Services Is Fueling Robust Growth

May 17, 2022

From LGM Pharma

Via Business Wire

LGM Pharma Launches Standalone Analytical Services for Drug Developers and Manufacturers

July 08, 2021

From LGM Pharma

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.